New Delhi [India], March 20 (ANI): Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity. Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro
Robert F. Kennedy Jr., the US Health Secretary, has cited “highly chemically processed foods” as a chief culprit behind an epidemic of chronic disease in the U.S., including ailments such as obesity, diabetes and autoimmune disorders. Such foods are “poisoning” people, particularly
Hyderabad, Mar 9 (PTI) At a time when India aspires to be a developed nation by 2047, the country cannot allow the energy of its younger generation to go waste due to diabetes, obesity and others which are spreading in epidemic proportions,
New Delhi, Mar 7 (PTI) New research has found a significant association between obesity and depression among middle- and older-aged adults in Ireland, with severe depressive symptoms likely among younger women having type 2 diabetes or less physical activity. Researchers said that
